Kobo Biotech Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|
| Revenue | 0.02 | TBA | TBA |
| Operating Expense | 0.34 | 0.25 | 0.20 |
| Net Profit | -1.33 | -1.26 | -1.23 |
| Net Profit Margin | -6,650 | TBA | TBA |
| Earning Per Share | -0.56 | -0.53 | -0.52 |
| EBIDTA | -0.32 | -0.25 | -0.20 |
| Effective Tax Rate | TBA | TBA | TBA |
| Particulars | Jun 2024 |
|---|---|
| Revenue | 0.02 |
| Operating Expense | 0.34 |
| Net Profit | -1.33 |
| Net Profit Margin | -6650.00 |
| Earning Per Share | -0.56 |
| EBIDTA | -0.32 |
| Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|
| Total Revenue Annual | TBA | TBA | TBA |
| Operating Expenses Annual | 1.50 | 10.50 | 2.79 |
| Operating Profit Annual | -1.48 | -10.49 | -2.75 |
| Interest Annual | 0.00 | 0.13 | 10.84 |
| Depreciation | 4.07 | 4.61 | 5.64 |
| Net Profit Annual | -5.55 | -15.23 | -19.23 |
| Tax Annual | TBA | TBA | TBA |
| Particulars | Mar 2023 |
|---|---|
| Total Revenue Annual | TBA |
| Operating Expenses Annual | 1.50 |
| Operating Profit Annual | -1.48 |
| Interest Annual | 0.00 |
| Depreciation | 4.07 |
| Net Profit Annual | -5.55 |
| Tax Annual | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.13 | 1.56 | 0.13 |
| Cash Flow from Operations | 0.87 | 93.76 | 2.51 |
| Cash Flow from Investing | TBA | 25.09 | TBA |
| Cash Flow from Financing | -0.87 | -120.28 | -1.08 |
| Cash Flow at the End | 0.13 | 0.13 | 1.56 |
| Particulars | Mar 2023 |
|---|---|
| Cash Flow at the Beginning | 0.13 |
| Cash Flow from Operations | 0.87 |
| Cash Flow from Investing | TBA |
| Cash Flow from Financing | -0.87 |
| Cash Flow at the End | 0.13 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|
| PBDIT Margin (%) | TBA | TBA | TBA |
| PBIT Margin (%) | TBA | TBA | TBA |
| PBT Margin (%) | TBA | TBA | TBA |
| Net PROFIT Margin (%) | TBA | TBA | TBA |
| Return On Networth / Equity (%) | TBA | TBA | TBA |
| Return On Networth /Employed (%) | TBA | TBA | TBA |
| Return On Assets (%) | TBA | TBA | TBA |
| Total Debt / Equity (X) | TBA | TBA | TBA |
| Asset Turnover Ratio (%) | TBA | TBA | TBA |
| Particulars | Mar 2023 |
|---|---|
| PBDIT Margin (%) | TBA |
| PBIT Margin (%) | TBA |
| PBT Margin (%) | TBA |
| Net PROFIT Margin (%) | TBA |
| Return On Networth / Equity (%) | TBA |
| Return On Networth /Employed (%) | TBA |
| Return On Assets (%) | TBA |
| Total Debt / Equity (X) | TBA |
| Asset Turnover Ratio (%) | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|
| Fixed Assets Annual | 37.59 | 41.66 | 56.91 |
| Total Current Assets Annual | 37.74 | 37.53 | 159.23 |
| Non Current Assets Annual | 37.59 | 41.66 | 71.36 |
| Total Shareholders Funds Annual | -127.98 | -122.43 | -107.20 |
| Total Assets Annual | 75.33 | 79.19 | 230.59 |
| Particulars | Mar 2023 |
|---|---|
| Fixed Assets Annual | 37.59 |
| Total Current Assets Annual | 37.74 |
| Non Current Assets Annual | 37.59 |
| Total Shareholders Funds Annual | -127.98 |
| Total Assets Annual | 75.33 |
No Data Availabe
